Regression of parathyroid gland swelling by treatment with cinacalcet

Nephrology Dialysis Transplantation

Volumn 24, Issue 2, 2009, Pages 690-691

  Terawaki, Hiroyuki ^a,b   Nakano, Hirofumi ^b   Takeguchi, Fumihiro ^b   Hasegawa, Toshio ^a,b   Nakayama, Masaaki ^b,c   Okazaki, Masao ^a   Hosoya, Tatsuo ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Kashima Hospital   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CINACALCET; PARATHYROID HORMONE; REGPARA; UNCLASSIFIED DRUG;

ADULT; CASE REPORT; CLINICAL FEATURE; FEMALE; HEMODIALYSIS; HORMONE RELEASE; HUMAN; HYPERPARATHYROIDISM; KIDNEY FAILURE; LABORATORY TEST; LETTER; PARATHYROID GLAND; PRIORITY JOURNAL;

CALCIUM; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; HYPERPLASIA; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; NAPHTHALENES; PARATHYROID GLANDS; RENAL DIALYSIS;

EID: 58449101025     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn579     Document Type: Letter

References (4)

1. Fukagawa M, Yumita S, Akizawa T et al. Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favourable control of the serum phosphorus and calcium levels in Japanese dialysis patients. Nephrol Dial Transplant 2008; 23: 328-335
2. Mizobuchi M, Ogata H, Hatamura I et al. Activation of calcium-sensing receptor accelerates apoptosis in hyperplastic parathyroid cells. Biochem Biophys Res Commun 2007; 362: 11-16
3. Kawata T, Imanishi Y, Kobayashi K et al. Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism. Eur J Endocrinol 2005; 153: 587-594
4. Lazar ES, Stankus N. Cinacalcet-induced hungry bone syndrome. Semin Dial 2007; 20: 83-85